Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Sales | 11,934,000 | 11,769,000 | 12,267,000 | 11,711,000 | 11,393,460 |
| Cost of Goods | 2,539,000 | 2,631,000 | 2,776,000 | 2,862,000 | 2,785,447 |
| Gross Profit | 9,395,000 | 9,138,000 | 9,491,000 | 8,850,000 | 8,608,013 |
| Operating Expenses | 7,156,000 | 6,941,000 | 7,480,000 | 6,520,000 | 6,541,876 |
| Operating Income | 2,238,000 | 2,197,000 | 2,012,000 | 2,329,000 | 2,066,584 |
| Interest Expense | 28,000 | 12,000 | 17,000 | 18,000 | 13,504 |
| Other Income | 41,000 | 58,000 | 63,000 | 205,000 | 119,611 |
| Pre-tax Income | 2,251,000 | 2,243,000 | 2,058,000 | 2,516,000 | 2,172,691 |
| Income Tax | 458,000 | 241,000 | 504,000 | 563,000 | 565,089 |
| Net Income Continuous | 1,793,000 | 2,002,000 | 1,554,000 | 1,953,000 | 1,607,602 |
| Net Income | $1,793,000 | $2,002,000 | $1,554,000 | $1,953,000 | $1,607,602 |
| EPS Basic Total Ops | 0.96 | 1.04 | 0.77 | 0.93 | 0.74 |
| EPS Basic Continuous Ops | 0.96 | 1.04 | 0.77 | 0.93 | 0.74 |
| EPS Diluted Total Ops | 0.95 | 1.04 | 0.76 | 0.92 | 0.74 |
| EPS Diluted Continuous Ops | 0.96 | 1.04 | 0.76 | 0.92 | 0.74 |
| EPS Diluted Before Non-Recurring Items | 0.96 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $2,848,000 | $2,769,000 | $2,623,000 | $2,899,000 | $2,640,844 |